J. Rhines

Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study

J. Kattwinkel, Cheng-Tao Chang, G. Dudell, 1998, Pediatrics.

Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn

J. Kattwinkel, G. Dudell, D. Davidson, 1999, Pediatrics.

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group.

J. Kattwinkel, G. Dudell, D. Davidson, 1998, Pediatrics.

Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.

P. Lipkin, D. Davidson, R. Straube, 2002, The Journal of pediatrics.

Naltrexone and alcohol dependence. Role of subject compliance.

A. Alterman, J. Volpicelli, C. O'brien, 1997, Archives of general psychiatry.

A DOUBLE MASKED, RANDOMIZED, PLACEBO CONTROLLED, DOSE-RESPONSE STUDY OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN). • 851

J. Kattwinkel, G. Dudell, D. Davidson, 1997, Pediatric Research.